Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nemaura Medical Inc (NQ: NMRD ) 0.1053 UNCHANGED Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nemaura Medical Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Nemaura Appoints New COO In Readiness For Manufacturing, Distribution Scale-Up February 14, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) recently... Via Benzinga BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022 February 14, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Nemaura (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing, Distribution Scale-Up February 14, 2022 Via Investor Brand Network Nemaura Marks History-Making Milestone With Initial Shipment Of CGM Devices January 28, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing and Distribution Scale-Up, Commercialization Phase of Growth February 11, 2022 Via Investor Brand Network Nemaura Set To Capitalize On Glucose Monitoring's Exponential Growth Rate February 10, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. The blood glucose monitoring system sector is expected to grow... Via Benzinga Nemaura (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring’s Exponential Growth Rate February 10, 2022 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring Sector’s Exponential Growth Rate February 09, 2022 Via Investor Brand Network Nemaura Commences Rollout Of Miboko Application February 04, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Nemaura (NASDAQ: NMRD) Commences Rollout of Miboko Application February 04, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Launch Leveraging ‘Most Reliable Gateway Toward Wider Adoption of Preventative Health Maintenance Practices’ February 03, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Nemaura Medical Appoints Healthcare Specialist Dr. Arash Ghadar as COO January 31, 2022 NMRD appoints UK-based Dr. Arash Ghadar as Chief Operating Officer, brings decades of healthcare and technology experience Dr. Ghadar previously supervised product development lifecycles, feasibility... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Appoints Healthcare Specialist Dr. Arash Ghadar as COO January 31, 2022 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Appoints Technical Healthcare Specialist Dr. Arash Ghadar as COO January 28, 2022 Via Investor Brand Network Nemaura (NASDAQ: NMRD) Marks History-Making Milestone with Initial Shipment of CGM Devices January 28, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks History Making Milestone with Initial Shipment of CGM Devices January 27, 2022 Via Investor Brand Network Nemaura Medical Commences Rollout of Miboko Application January 25, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical is a medical technology... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Commences Rollout of Miboko Application January 25, 2022 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution January 24, 2022 Via Investor Brand Network Nemaura Medical Firmly Positioned in Growing Diabetes Tech Market January 21, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Diabetes tech market expanded in 2021... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market January 21, 2022 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee January 20, 2022 Via Investor Brand Network Nemaura Medical Launches Miboko – A New Metabolic Health Program January 14, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Launches Miboko – A New Metabolic Health Program January 14, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Launches Miboko – a New Metabolic Health Program January 13, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Nemaura Medical Names Industry Veteran as COO January 11, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Names Industry Veteran as COO January 11, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names Industry Veteran as COO January 10, 2022 Via Investor Brand Network Nemaura Medical to Present at H.C. Wainwright Bioconnect Conference January 10, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... Via Benzinga Nemaura Medical (NASDAQ: NMRD) to Present at H.C. Wainwright Bioconnect Conference January 10, 2022 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.